Page last updated: 2024-12-05

dibenzyl disulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dibenzyl disulfide (DBDS) is a naturally occurring organosulfur compound found in various plants, including garlic and onion. It exhibits antimicrobial and antioxidant properties, potentially contributing to the health benefits associated with these plants. DBDS is synthesized through the oxidation of benzyl mercaptan. Research focuses on its potential applications in medicine, agriculture, and food preservation due to its antimicrobial and antioxidant properties. For instance, studies have explored its efficacy in inhibiting bacterial growth and reducing oxidative stress in cells. Additionally, DBDS has shown promise as a potential agent for controlling plant diseases and improving food shelf life.'

dibenzyl disulfide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dibenzyl disulfide : An organic disulfide that results from the formal oxidative dimerisation of benzyl thiol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9012
CHEMBL ID121047
CHEBI ID72752
SCHEMBL ID160895
MeSH IDM0473990

Synonyms (77)

Synonym
dibenzyldisulfid
150-60-7
wln: r1ss1r
nsc6841
1,3-dithiabutane
.alpha.-(benzyldithio)toluene
benzyl disulfide
benzyl bisulfide
disulfide, bis(phenylmethyl)
nsc-6841
di(phenylmethyl)disulfide
dibenzyl disulfide
disulfide, dibenzyl
BDS ,
benzyldisulfide
nsc-677465
4,4'-biphenyldiglyoxal disodium bisulfite
fema no. 3617
nsc 6841
dibenzyl disulphide
1,4-diphenyl-2,3-dithiobutane
einecs 205-764-0
di(phenylmethyl) disulfide
alpha-(benzyldithio)toluene
nsc 677465
1,4-diphenyl-2,3-dithiabutane
ccris 6924
dibenzyldisulfid [czech]
bis(phenylmethyl) disulfide
1,1'-[dithiobis(methylene)]dibenzene
inchi=1/c14h14s2/c1-3-7-13(8-4-1)11-15-16-12-14-9-5-2-6-10-14/h1-10h,11-12h
nsc677465
(benzyldisulfanyl)methylbenzene
diphenylmethyl disulfide
GHL.PD_MITSCHER_LEG0.312 ,
dibenzyl disulfide, 98%
benzyl disulfide, 98%, fg
B0417
1,1'-(disulfanediyldimethanediyl)dibenzene
STK831913
CHEMBL121047
chebi:72752 ,
A809057
[(benzyldisulfanyl)methyl]benzene
unii-bg7680605n
bg7680605n ,
AKOS005177808
FT-0624652
dibenzyldisulfide
dailube s 700
benzyl disulfide [fhfi]
benzyl disulfide [usp-rs]
dibenzyl disulfide [mi]
1,2-dibenzyldisulfane
benzyl disulphide
dibenzyldisulphide
dibenzyl-disulfide
SCHEMBL160895
DTXSID6059738
[(benzyldisulfanyl)methyl]benzene #
dibenzyl disulfide, analytical standard
mfcd00004783
benzyl disulfide, united states pharmacopeia (usp) reference standard
bis(phenylmethyl) disulfide, 9ci
benzyldisulfanyl-methyl-benzene
fema 3617
benzyl disulfide, 8ci
benzyl disulfide (8ci)
J-008720
Q27140119
CS-W010232
D77707
HY-W009516
EN300-16500
dibenzyl disulfide 2 microg/ml in transformer oil
dibenzyl disulfide 10 microg/ml in transformer oil
Z55949860
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic disulfideCompounds of structure RSSR in which R and R' are organic groups.
organic aromatic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID89802Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
AID681123TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID681133TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID89654Inhibition of HIV-1 replication in human T-cell by using XTT assay; Inactive1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.15 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index40.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]